SANA · ISSUER CIK 1770121
Sana Biotechnology, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Sana Biotechnology, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:42 | Oct 5, 2026 | SANA | Director | A · Grant | — | +8,680 | 5,863,480 | +0% | — | ||
| Aug 27, 202616:21 | Aug 26, 2026 | SANA | EVP, Chief Scientific Officer | M · Exercise | — | +125,000 | 224,510 | +126% | — | ||
| Aug 27, 202616:21 | Aug 27, 2026 | SANA | EVP, Chief Scientific Officer | F · Tax | $4.11 | −41,158 | 183,352 | -18% | $169K |